Bohrer LR - Search Results

1

LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.

He Y, Zhao Y, Wang L, Bohrer LR, Pan Y, Wang L, Huang H. He Y, et al. Among authors: bohrer lr. Oncogene. 2018 Jan 25;37(4):534-543. doi: 10.1038/onc.2017.353. Epub 2017 Oct 9. Oncogene. 2018. PMID: 28991226

2

Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.

Bohrer LR, Chen S, Hallstrom TC, Huang H. Bohrer LR, et al. Endocrinology. 2010 Nov;151(11):5136-45. doi: 10.1210/en.2010-0436. Epub 2010 Sep 29. Endocrinology. 2010. PMID: 20881251 Free PMC article.

3

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.

Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA, Huang H. Chen S, et al. Among authors: bohrer lr. Nat Cell Biol. 2010 Nov;12(11):1108-14. doi: 10.1038/ncb2116. Epub 2010 Oct 10. Nat Cell Biol. 2010. PMID: 20935635 Free PMC article.

4

p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.

Zhong J, Ding L, Bohrer LR, Pan Y, Liu P, Zhang J, Sebo TJ, Karnes RJ, Tindall DJ, van Deursen J, Huang H. Zhong J, et al. Among authors: bohrer lr. Cancer Res. 2014 Mar 15;74(6):1870-1880. doi: 10.1158/0008-5472.CAN-13-2485. Epub 2014 Jan 30. Cancer Res. 2014. PMID: 24480624 Free PMC article.

5

FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.

Bohrer LR, Liu P, Zhong J, Pan Y, Angstman J, Brand LJ, Dehm SM, Huang H. Bohrer LR, et al. Prostate. 2013 Jul;73(10):1017-27. doi: 10.1002/pros.22649. Epub 2013 Feb 6. Prostate. 2013. PMID: 23389878 Free PMC article.

6

Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.

Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H. Gan L, et al. Cancer Res. 2009 Nov 1;69(21):8386-94. doi: 10.1158/0008-5472.CAN-09-1504. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826044 Free PMC article.

7

Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.

Farooqui M, Bohrer LR, Brady NJ, Chuntova P, Kemp SE, Wardwell CT, Nelson AC, Schwertfeger KL. Farooqui M, et al. Among authors: bohrer lr. Mol Cancer. 2015 Jul 29;14:138. doi: 10.1186/s12943-015-0408-z. Mol Cancer. 2015. PMID: 26215578 Free PMC article.

8

Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.

Bohrer LR, Chuntova P, Bade LK, Beadnell TC, Leon RP, Brady NJ, Ryu Y, Goldberg JE, Schmechel SC, Koopmeiners JS, McCarthy JB, Schwertfeger KL. Bohrer LR, et al. Cancer Res. 2014 Jan 1;74(1):374-86. doi: 10.1158/0008-5472.CAN-13-2469. Epub 2013 Nov 6. Cancer Res. 2014. PMID: 24197137 Free PMC article.

9

Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner.

Bohrer LR, Schwertfeger KL. Bohrer LR, et al. Mol Cancer Res. 2012 Oct;10(10):1294-305. doi: 10.1158/1541-7786.MCR-12-0275. Epub 2012 Aug 14. Mol Cancer Res. 2012. PMID: 22893608 Free PMC article.

10

ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation.

Bohrer LR, Chaffee TS, Chuntova P, Brady NJ, Witschen PM, Kemp SE, Nelson AC, Walcheck B, Schwertfeger KL. Bohrer LR, et al. Genes Cancer. 2016 Jul;7(7-8):240-253. doi: 10.18632/genesandcancer.115. Genes Cancer. 2016. PMID: 27738494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters